Philadelphia, PA, United States of America

H Lee Sweeney




Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of H Lee Sweeney in Muscle Disease Research

Introduction

H Lee Sweeney, an accomplished inventor based in Philadelphia, PA, has made significant strides in the field of muscular atrophy and degenerative muscle disease. With a total of three patents to his name, his work focuses on advanced treatment methodologies that utilize the Bowman-Birk Inhibitor (BBI) to enhance muscle function and address critical muscle-related disorders.

Latest Patents

Sweeney's latest innovations center around the use of BBI for therapeutic applications. His patents highlight methods for employing a composition comprising Bowman-Birk Inhibitor or its derivatives in the treatment and prevention of skeletal muscle atrophy. These compositions aim to improve muscle function while alleviating symptoms and potentially slowing the progression of degenerative skeletal muscle diseases or disorders.

Career Highlights

Throughout his career, H Lee Sweeney has demonstrated a commitment to advancing medical research and treatment options. His association with the University of Pennsylvania has provided him with a platform to pursue his innovative research and collaborate with leading experts in the field.

Collaborations

Sweeney has worked alongside notable colleagues such as Carl A Morris and Ann R Kennedy, contributing to a collaborative environment that fosters innovation and discovery in muscle disease research.

Conclusion

H Lee Sweeney's contributions to the field of muscular atrophy and degenerative muscle disease through his patents exemplify the impact of dedicated inventors in healthcare. His work not only offers hope for improved treatment options but also highlights the importance of research and collaboration in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…